Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 immunoanalyzer.
OBJECTIVE
We evaluated the analytical performance of the Elecsys 2010 immunoanalyzer (Boehringer Mannheim Canada), which is based on a new detection technology, electrochemical luminescence.


METHODS
We used six representative assays from the initial launch menu of the instrument: thyroid stimulating hormone (TSH), free thyroxine (FT4), troponin T, human chorionic gonadotropin (hCG), carcinoembryonic antigen (CEA), and prostate specific antigen (PSA). Within-run and between-day imprecision were evaluated using pools of human specimens at low, mid and high concentrations. Linearity was evaluated by diluting specimens with high analyte concentrations with specimens that had a low level of this analyte. Carry over and hook effect were investigated using specimens with high concentrations of hCG. Functional sensitivity was studied by running low TSH specimens over 21 daily runs, and by comparing the scatterplot of FT4 as a function of TSH. Over 100 specimens distributed across the analytical range were analyzed with two comparison methods: ES 300 (Boehringer Mannheim Canada) and AxSYM (Abbott Laboratories).


RESULTS
Within-run and between-day imprecisions were less than 4% and 10%, respectively, for most assays. All assays were linear over the whole analytical range. Carry over was minimal (< 0.0002%). A hook effect was present for hCG levels greater than 560,000 U/L. The functional sensitivity of the TSH assay was lower than 0.02 mlU/L. Correlation coefficients were all > 0.94. Small proportional errors were observed in comparison studies for the CEA and PSA assays.


CONCLUSIONS
The Elecsys 2010 system was shown to have an acceptable analytical performance for the rapid analysis of a wide variety of analytes. The hook effect observed with hCG assay would imply that the laboratory informs the clinicians of the possibility of falsely low values in trophoblastic diseases or that all specimens with values greater than 3000 U/L are reassayed after dilution.
Forest
J C
JC
Department of Biochemistry, Faculty of Medicine, Laval University, C.H.U.Q., Canada.
Massé
J
J
Lane
A
A
D001322:Autoanalysis / Q000295:instrumentation / Q000379:methods; D001774:Blood Chemical Analysis / Q000295:instrumentation* / Q000379:methods; D002272:Carcinoembryonic Antigen / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D004563:Electrochemistry / Q000295:instrumentation / Q000379:methods; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000295:instrumentation* / Q000379:methods; D016018:Least-Squares Analysis; D008163:Luminescent Measurements; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014336:Troponin / Q000032:analysis; D020107:Troponin T
D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D014336:Troponin; D020107:Troponin T; D013972:Thyrotropin; D017430:Prostate-Specific Antigen; D013974:Thyroxine